022sek
-2,7 %
Date:2026-09-09Time:18:00:00Latest report:Q2-2026List:First NorthTicker:ACARIX
Market Cap:267 msekEnterprise Value:238 msekNet Sales:9,22 msekEarnings:-39,4 msekEmployees:0ISIN:SE0009268717

Ratios

10-year key figure history for Acarix turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Acarix with index and moving average MA50 and MA200.

Stockprice:0,22
MA50:0,25
MA200:0,27
Price/MA200:-19,8 %
RSI (14):30,6
Price/MA50:-12,5 %

Description

Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.

Medical Equipment